LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | R406 | 0.37 | uM | LJP6 | 72 | hr | 1657 | 5581 | 5505 | 1.0138 | 1.0198 |
BT-20 | Pictilisib | 0.37 | uM | LJP6 | 72 | hr | 1657 | 3203 | 5505 | 0.5818 | 0.4016 |
BT-20 | Gefitinib | 0.37 | uM | LJP6 | 72 | hr | 1657 | 5237 | 5505 | 0.9513 | 0.9304 |
BT-20 | Geldanamycin | 0.37 | uM | LJP5 | 72 | hr | 1657 | 1776 | 5505 | 0.3226 | 0.0307 |
BT-20 | Geldanamycin | 0.37 | uM | LJP6 | 72 | hr | 1657 | 1855 | 5505 | 0.3370 | 0.0514 |
BT-20 | GSK1059615 | 0.37 | uM | LJP5 | 72 | hr | 1657 | 1994 | 5505 | 0.3623 | 0.0876 |
BT-20 | GSK1059615 | 0.37 | uM | LJP6 | 72 | hr | 1657 | 1728 | 5505 | 0.3140 | 0.0184 |
BT-20 | GSK1904529A | 0.37 | uM | LJP6 | 72 | hr | 1657 | 5067 | 5505 | 0.9204 | 0.8861 |
BT-20 | Omipalisib | 0.37 | uM | LJP6 | 72 | hr | 1657 | 1307 | 5505 | 0.2374 | -0.0912 |
BT-20 | GSK 690693 | 0.37 | uM | LJP5 | 72 | hr | 1657 | 4300 | 5505 | 0.7810 | 0.6867 |
BT-20 | GW843682X | 0.37 | uM | LJP6 | 72 | hr | 1657 | 2170 | 5505 | 0.3943 | 0.1333 |
BT-20 | HG-5-113-01 | 0.37 | uM | LJP5 | 72 | hr | 1657 | 4390 | 5505 | 0.7974 | 0.7102 |
BT-20 | HG-5-88-01 | 0.37 | uM | LJP6 | 72 | hr | 1657 | 5293 | 5505 | 0.9614 | 0.9448 |
BT-20 | Imatinib | 0.37 | uM | LJP6 | 72 | hr | 1657 | 5458 | 5505 | 0.9914 | 0.9877 |
BT-20 | JNK-9L | 0.37 | uM | LJP6 | 72 | hr | 1657 | 3193 | 5505 | 0.5800 | 0.3990 |
BT-20 | JW-7-24-1 | 0.37 | uM | LJP6 | 72 | hr | 1657 | 4627 | 5505 | 0.8405 | 0.7717 |
BT-20 | Lapatinib | 0.37 | uM | LJP6 | 72 | hr | 1657 | 5384 | 5505 | 0.9779 | 0.9684 |
BT-20 | LDN-193189 | 0.37 | uM | LJP5 | 72 | hr | 1657 | 5405 | 5505 | 0.9818 | 0.9739 |
BT-20 | Linifanib | 0.37 | uM | LJP6 | 72 | hr | 1657 | 5855 | 5505 | 1.0634 | 1.0908 |
BT-20 | Linsitinib | 0.37 | uM | LJP5 | 72 | hr | 1657 | 4992 | 5505 | 0.9067 | 0.8665 |
BT-20 | Mitoxantrone | 0.37 | uM | LJP5 | 72 | hr | 1657 | 1726 | 5505 | 0.3136 | 0.0179 |
BT-20 | Mitoxantrone | 0.37 | uM | LJP6 | 72 | hr | 1657 | 1719 | 5505 | 0.3123 | 0.0160 |
BT-20 | MK2206 | 0.37 | uM | LJP6 | 72 | hr | 1657 | 3982 | 5505 | 0.7234 | 0.6042 |
BT-20 | Neratinib | 0.37 | uM | LJP5 | 72 | hr | 1657 | 4244 | 5505 | 0.7708 | 0.6721 |
BT-20 | Nilotinib | 0.37 | uM | LJP5 | 72 | hr | 1657 | 5513 | 5505 | 1.0014 | 1.0020 |